Related Experiment Videos
Paranoid psychosis due to flecainide toxicity in malignant neuropathic pain
1St. James's University Hospital, Leeds, UK.
Pain
|March 1, 1997
Abstract:
Flecainide was used to treat malignant neuropathic pain but despite using therapeutic doses, toxicity occurred resulting in paranoid psychosis. Monitoring of flecainide levels in vulnerable populations is suggested to guide prescribing.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Which factors can aid clinicians to identify a risk of pain during the following month in patients with bone metastases? A longitudinal analyses.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2018
Neuropathic pain in cancer: systematic review, performance of screening tools and analysis of symptom profiles.
British journal of anaesthesia·2017
Diagnosing postoperative neuropathic pain: a Delphi survey.
British journal of anaesthesia·2012
Death rattle: an audit of hyoscine (scopolamine) use and review of management.
Journal of pain and symptom management·1996
Personal computer teleradiology interhospital image transmission of neonatal radiographs to facilitate tertiary neonatology telephone consultation and patient transfer.
Journal of perinatology : official journal of the California Perinatal Association·1996
When CO2 sensing fails: Protective effects of sex hormones and potential mechanisms.
Journal of neuroendocrinology·2026
Survival in unresectable hepatocellular carcinoma: Comparison of four treatments based on patients reconstructed from Kaplan-Meier curves of randomized trials.
World journal of gastrointestinal pharmacology and therapeutics·2026
Acupuncture Suppresses the ER Stress-JNK Pathway to Inhibit Chondrocyte Apoptosis and Attenuate Knee Osteoarthritis.
Cell stress & chaperones·2026
Schisantherin B mitigates cisplatin-induced ototoxicity by modulating the CNPY2-PERK/CHOP signaling axis.
Biochemical pharmacology·2026